Asset Details
Do you wish to reserve the book?
Anticancer effect of quinacrine on diffuse large B-cell lymphoma via inhibition of MSI2-NUMB signaling pathway
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Anticancer effect of quinacrine on diffuse large B-cell lymphoma via inhibition of MSI2-NUMB signaling pathway
Do you wish to request the book?
Anticancer effect of quinacrine on diffuse large B-cell lymphoma via inhibition of MSI2-NUMB signaling pathway
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Anticancer effect of quinacrine on diffuse large B-cell lymphoma via inhibition of MSI2-NUMB signaling pathway
2018
Overview
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin's lymphoma. Despite improvements in the clinical outcomes of DLBCL, ~30% of patients will develop relapse/refractory disease. Therefore, novel therapeutic drugs have been investigated to improve disease outcomes. Previous studies have revealed the anticancer effects of quinacrine (QC) on tumor cells in vitro, although its role in human DLBCL is yet to be identified. The present study sought to examine the cytotoxic effect of QC on DLBCL cells. QC induced G0/G1 cell cycle arrest and apoptosis in the DLBCL cell lines SU-DHL-8 and OCI-LY01, in a dose-dependent manner, in addition to the downregulation of cyclin-dependent kinase 4/6 and the upregulation of cleaved poly-ADP ribose polymerase 1. Upon exposure to QC, RNA-binding protein Musashi homolog 2 inactivation and activation of protein numb homolog were observed. In addition, QC was able to inhibit the expression of Myc proto-oncogene protein. The results of the present study indicated that QC may be a potential anti-DLBCL drug.
Publisher
D.A. Spandidos,Spandidos Publications,Spandidos Publications UK Ltd
Subject
Antineoplastic Agents - pharmacology
/ Cell Proliferation - drug effects
/ Cellular signal transduction
/ diffuse large B-cell lymphoma
/ Humans
/ Kinases
/ Lymphoma
/ Lymphoma, Large B-Cell, Diffuse - metabolism
/ Membrane Proteins - metabolism
/ Nerve Tissue Proteins - metabolism
/ Proteins
/ Proto-Oncogene Proteins c-myc - metabolism
/ Ribose
/ RNA
/ RNA-binding protein Musashi homolog 2-protein numb homolog signaling pathway
/ RNA-Binding Proteins - metabolism
/ Signal Transduction - drug effects
/ Software
/ Studies
